IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tyndall Capital Partners L P

Q1 2025 Holdings

Filed 2025-05-15 | 1 holdings | $411.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cyclerion Therapeutics Inc(CYCN)COM23255M204$411.9K164,777100.0%